Thomas E. Witzig
0000-0002-4215-6500
Publication & Citation Trends
Publications
0 total
Anatomical Localization–Based Analysis of Relapsed Secondary Central Nervous System Aggressive B‐Cell Lymphoma (R‐SCNSL)
Cited by 0
Semantic Scholar
Optimizing low dose radiotherapy for indolent lymphomas: comparing 8 Gy in 2 fractions to 4 Gy in 2 fractions
Cited by 0
Semantic Scholar
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes.
Cited by 0
Semantic Scholar
Multi‐Institutional Study of ALK‐Positive Large B‐Cell Lymphoma: Outcomes in the Era of ALK Inhibitors and Biologically Informed Therapies
Cited by 0
Semantic Scholar
Performance of molecular classifiers relative to the international prognostic index (IPI) for overall and event-free survival in diffuse large B-cell lymphoma (DLBCL)
Cited by 0
Semantic Scholar
Cardiovascular degeneration in Erdheim-Chester disease: prevalence, burden, and outcomes
Cited by 0
Semantic Scholar
Anatomical localization-based analysis of de novo secondary cns lymphoma
Cited by 0
Semantic Scholar
Efficacy of frontline fixed duration chemotherapy in MAPK-pathway altered adult langerhans cell histiocytosis: A multi-institutional international retrospective study
Cited by 0
Semantic Scholar
Research Topics
Lymphoma Diagnosis and Treatment
(715)
Chronic Lymphocytic Leukemia Research
(398)
Multiple Myeloma Research and Treatments
(188)
Viral-associated cancers and disorders
(109)
CAR-T cell therapy research
(106)
Affiliations
Université Claude Bernard Lyon 1
Northwestern University
University of Nebraska–Lincoln
University of Nebraska at Omaha
Novartis (Switzerland)